




Searching News Database: tramadol
HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
HSMN NewsFeed - 7 May 2009
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
HSMN NewsFeed - 20 Apr 2009
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
HSMN NewsFeed - 17 Feb 2009
Cipher receives tentative FDA approval for extended-release tramadol capsules
Cipher receives tentative FDA approval for extended-release tramadol capsules
HSMN NewsFeed - 22 Sep 2008
Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression
Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression
HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
HSMN NewsFeed - 28 Apr 2008
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer
HSMN NewsFeed - 18 Apr 2008
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
HSMN NewsFeed - 1 Feb 2008
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
HSMN NewsFeed - 24 Jan 2008
Labopharm Receives FDA Response To Recent Appeal Of Approvable Letter For Once-Daily Tramadol
Labopharm Receives FDA Response To Recent Appeal Of Approvable Letter For Once-Daily Tramadol
HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed - 21 Nov 2007
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
HSMN NewsFeed - 24 Sep 2007
Labopharm provides update on U.S. regulatory process for once-daily Tramadol
Labopharm provides update on U.S. regulatory process for once-daily Tramadol
HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
HSMN NewsFeed - 19 Jul 2007
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
HSMN NewsFeed - 19 Jul 2007
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
HSMN NewsFeed - 11 Jul 2007
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
HSMN NewsFeed - 11 Jul 2007
Labopharm Completes South Korean Licensing and Distribution Agreement for Once-Daily Tramadol
Labopharm Completes South Korean Licensing and Distribution Agreement for Once-Daily Tramadol
HSMN NewsFeed - 10 Jul 2007
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
HSMN NewsFeed - 29 Jun 2007
Labopharm meets with FDA to discuss second Approvable Letter for once-daily tramadol
Labopharm meets with FDA to discuss second Approvable Letter for once-daily tramadol
HSMN NewsFeed - 7 Jun 2007
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone
HSMN NewsFeed - 31 May 2007
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
HSMN NewsFeed - 3 May 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
HSMN NewsFeed - 27 Apr 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
HSMN NewsFeed - 9 Jan 2007
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
HSMN NewsFeed - 20 Dec 2006
Labopharm submits response to approvable letter for once-daily Tramadol to FDA
Labopharm submits response to approvable letter for once-daily Tramadol to FDA
HSMN NewsFeed - 18 Jul 2006
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed - 9 May 2006
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium
Additional items found! 51

Members Archive contains
51 additional stories matching:
tramadol
(Password required)
tramadol
(Password required)